A preliminary clinical trial to evaluate 64Cu-NOTA-Trastuzumab as a positron emission tomography imaging agent in patients with breast cancer.

Inki LeeIlhan LimByung Hyun ByunByung Il KimChang Woon ChoiSang-Keun WooKwang Il KimKyo Chul LeeJoo Hyun KangMin-Ki SeongHyun-Ah KimWoo Chul NohSang Moo Lim

Published in: EJNMMI research (2021)

CRIS, KCT0002790. Registered 02 February 2018, https://cris.nih.go.kr.

Keyphrases

positron emission tomography
clinical trial
computed tomography
high resolution
pet imaging
pet ct
epidermal growth factor receptor
phase ii
study protocol
open label
metastatic breast cancer
randomized controlled trial
aqueous solution
tyrosine kinase
photodynamic therapy
mass spectrometry